20 completed, 11 unknown, 6 terminated, 1 active not recruiting. 38 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 38 | Completed 20, Unknown 11, Terminated 6, Active not recruiting 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Carmustine: new trials by email Literature Review of Carmustine trials Research Report on Carmustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ChiCGB vs BEAM in High-risk or R/R Lymphomas Chidamide, Cladribine, Gemcitabine - Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell | Phase 3 | Unknown | Sichuan University | 306 | 2022-07-01 | 2022-07-25 |
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Autologous Bone Marrow Transplantation, Autologous Hematopoietic Stem Cell Transplantation, Carmustine - Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 94 | 2016-10-12 | 2026-11-13 |
| BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL 90-Yttrium Ibritumomab tiuxetan, Carmustine, Etoposide - Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 3 | Terminated | City of Hope Medical Center | 3 | 2015-01-01 | 2018-03-12 |
| Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma Carmustine, tumor resection surgery - Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 3 | Unknown | Shandong Lanjin Pharmaceuticals Co.,Ltd | 236 | 2012-08-01 | 2012-08-03 |
| Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma trabedersen, temozolomide, Drug delivery system for administration of AP 12009 - Anaplastic Astrocytoma, Glioblastoma | Phase 3 | Terminated | Isarna Therapeutics GmbH | 27 | 2008-12-01 | 2014-11-14 |
| Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma bleomycin sulfate, ABVD regimen, carmustine - Lymphoma | Phase 3 | Terminated | French Innovative Leukemia Organisation | 442 | 2008-05-01 | 2016-09-16 |
| Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma Rituximab, Ciclofosfamide, Doxorubicina - Diffuse Large B-Cell Lymphoma, IPI≥2 | Phase 3 | Unknown | Fondazione Italiana Linfomi - ETS | 399 | 2006-01-01 | 2011-02-15 |
| Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Cyclophosphamide and Rituximab, Filgrastim, Chemotherapy or Radiation therapy - Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma | Phase 2 / Phase 3 | Terminated | Medical College of Wisconsin | 30 | 2004-08-01 | 2023-01-05 |
| Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL Rituximab, Cyclophosphamide, Doxorubicin - Lymphoma, Mantle-Cell | Phase 3 | Unknown | European Mantle Cell Lymphoma Network | 360 | 2004-07-01 | 2012-09-10 |
| The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme IL13-PE38QQR, surgery and catheter placement (2 procedures), prolifespan 20 with carmustine implant (GLIADEL® Wafer) - Glioblastoma Multiforme | Phase 3 | Completed | INSYS Therapeutics Inc | 300 | 2004-02-01 | 2011-06-06 |
| Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma aldesleukin, filgrastim, recombinant interferon gamma - Lymphoma | Phase 2 / Phase 3 | Completed | Children's Oncology Group | 24 | 2003-11-01 | 2013-10-17 |
| Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme Edotecarin, Temozolomide, Carmustine (BCNU) - Glioblastoma | Phase 3 | Completed | Pfizer | 118 | 2003-08-01 | 2008-04-01 |
| R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma Rituximab, Etoposide, Carboplatine - Lymphoma, Large-Cell, Diffuse | Phase 3 | Completed | Lymphoma Study Association | 481 | 2003-06-01 | 2019-08-28 |
| Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma filgrastim, rituximab, carmustine - Lymphoma | Phase 3 | Completed | Eastern Cooperative Oncology Group | 427 | 2003-03-01 | 2009-02-09 |
| S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma carmustine, radiation therapy, O6-Benzylguanine - Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System | Phase 3 | Completed | SWOG Cancer Research Network | 183 | 2001-09-01 | 2013-01-30 |
| Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma filgrastim, carmustine, cisplatin - Lymphoma | Phase 3 | Unknown | German Hodgkin's Lymphoma Study Group | 220 | 2001-07-01 | 2013-09-17 |
| Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma filgrastim, recombinant interferon alfa, carmustine - Lymphoma | Phase 3 | Unknown | German Low Grade Lymphoma Study Group | 2000-12-01 | 2013-09-17 | |
| Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma filgrastim, rituximab, carmustine - Lymphoma | Phase 3 | Completed | Commissie Voor Klinisch Toegepast Onderzoek | 340 | 2000-09-01 | 2013-08-12 |
| Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas BCNU 80mg/m2, TMZ 200mg/m2, radiation therapy - Brain and Central Nervous System Tumors | Phase 3 | Completed | Radiation Therapy Oncology Group | 230 | 2000-06-01 | 2019-09-12 |
| S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease bleomycin sulfate, carmustine, cyclophosphamide - Lymphoma | Phase 3 | Terminated | SWOG Cancer Research Network | 11 | 2000-04-01 | 2013-01-24 |
Showing 20 of 38. Sign in to see all of them.
Lymphoma (15) · Lymphoma, Large B-Cell, Diffuse (10) · Glioblastoma (8) · Astrocytoma (6) · Lymphoma, Follicular (6) · Lymphoma, Non-Hodgkin (5) · Multiple Myeloma (5) · Central Nervous System Neoplasms (4) · Glioma (4) · Hodgkin Disease (4) · Lymphoma, Large-Cell, Immunoblastic (4) · Brain Neoplasms (3) · Gliosarcoma (3) · Neoplasms (3) · Breast Neoplasms (2)
SWOG Cancer Research Network (5) · Radiation Therapy Oncology Group (3) · European Organisation for Research and Treatment of Cancer - EORTC (2) · M.D. Anderson Cancer Center (2) · Medical Research Council (2) · National Cancer Institute (NCI) (2) · Children's Oncology Group (1) · City of Hope Medical Center (1) · Colorado Health Foundation (1) · Commissie Voor Klinisch Toegepast Onderzoek (1) · EBMT Solid Tumors Working Party (1) · Eastern Cooperative Oncology Group (1) · European Mantle Cell Lymphoma Network (1) · Fondazione Italiana Linfomi - ETS (1) · French Innovative Leukemia Organisation (1)
United States (21) · United Kingdom (9) · Canada (8) · Germany (8) · Belgium (6) · France (5) · Italy (5) · Australia (4) · Austria (4) · Czechia (4) · Netherlands (4) · Poland (4) · Switzerland (4) · Denmark (3) · Israel (3)
David C. Linch (2) · Achiel Van Hoof, MD (1) · Alessandro Levis, MD (1) · Alexander M. Spence, MD (1) · Allen R. Chen, MD, PhD, MHS (1) · Amrita Y. Krishnan MD, MD (1) · Andreas Engert, MD (1) · Antonio C. Wolff, MD (1) · Bart Barlogie, M.D., Ph.D. (1) · Bart Barlogie, MD (1) · Charalambos B Andreadis (1) · Charles A. Linker, MD (1) · Christian Gisselbrecht (1) · Clifford A. Hudis, MD (1) · David P. Schenkein, MD (1)
PMID 22689675, PMID 15234047, PMID 15465203, PMID 15761020, PMID 15890570, PMID 16033132, PMID 16432076, PMID 16525139, PMID 16932345, PMID 17339189, PMID 17404368, PMID 17971487, PMID 18077791, PMID 18248979, PMID 20032498, PMID 20383558, PMID 20660832, PMID 21073974, PMID 23091101, PMID 23547078, PMID 24171516, PMID 24625415, PMID 24687837, PMID 25407559, PMID 26022239, PMID 27313086, PMID 27581518, PMID 28327958, PMID 28668386, PMID 32817282, PMID 36469833, PMID 40471585, PMID 40501401, PMID 41850328, PMID 8058153
U10CA032102 (5), P30CA016672 (2), P30CA008748 (1), U01HL069294 (1), U10CA021115 (1), U10CA180821 (1), U24CA076518 (1)